| |

Radioimmunontherapy (RIT) for follicular lymphoma

ByRod Adams

Andrew Schorr, the founder and host of Patient Power, interviewed Dr. Anton Hagenbeek of the University Medical Center Utrecht Netherlands about the result of clinical trials of radioimmunotherapy (RIT) to combat follicular lymphoma. The treatment uses a monoclonal antibody that is covalently bound to Y-90, which is a beta emitter. The monoclonal antibody selectively binds itself to the cancer cells to allow the Y-90 betas to target and destroy the invasive tissue.

Dr. Hagenbeek agreed when Schorr described this approach as a smart bomb approach that produces less damage to innocent bystanders. Though I have no intention of attempting to summarize the lengthy discussion, I will say that I was impressed when Dr. Hagenbeek favorably compared the effectiveness of a single dose of RIT to 16 injections of rituximab (one every 2-3 months over a three year period.) He was surprisingly reserved in his description of the incredible lifestyle improvement that the single dose of radioimmunotherapy provides compared to the 16 doses of chemotherapy.

Robert Schenter shared the above video interview which was conducted at the American Society of Hematology Meeting in 2011. This video has been available on YouTube for about 18 months, but it has only been viewed about 215 times. It is hard to believe that such interesting news about a cost and time effective cancer treatment has received such little attention.

Rod Adams
Rod Adams

Rod Adams is Managing Partner of Nucleation Capital, a venture fund that invests in advanced nuclear, which provides affordable access to this clean energy sector to pronuclear and impact investors. Rod, a former submarine Engineer Officer and founder of Adams Atomic Engines, Inc., which was one of the earliest advanced nuclear ventures, is an atomic energy expert with small nuclear plant operating and design experience. He has engaged in technical, strategic, political, historic and financial analysis of the nuclear industry, its technology, regulation, and policies for several decades through Atomic Insights, both as its primary blogger and as host of The Atomic Show Podcast. Please click here to subscribe to the Atomic Show RSS feed. To join Rod's pronuclear network and receive his occasional newsletter, click here.

One Comment

  1. Because it is radiation. God forbid anything good comes out of radiation even though life evolved during the Archean and Proterozoic with much higher levels of background radiation.

Comments are closed.

Similar Posts

  • Using science to update regulatory approach to radiation protection

    ByRod Adams

    Excessive regulation of extremely low radiation doses increases the public fears of nuclear technology, increases the costs borne by society, and can deprive society of the full benefit of that technology.” – Edward Maher, Sc.D., Harvard University Note: Borrowed from lowdoserad.org That is a truth that Atomic Insights has recognized for many years, but the…

  • Enabling atomic innovation

    ByRod Adams

    During the past several weeks there have been a number of developments supporting a growing movement to enable nuclear energy innovators to succeed in the US. Leaders are realizing that nuclear energy, which has deep roots in the US and has proven its capability to produce reliable power without producing any air pollution, should be…

  • Spirited debate about BEIR VII and Linear No Threshold (LNT) Dose Assumption

    ByRod Adams

    A few days ago, I wrote What should “Radioactive Wolves” teach critical thinkers? and promptly got really busy at work. I put in several “half-days” (Navy lingo for a 12 hour work day) and did not have much time for paying attention to Atomic Insights. When I finally got around to checking on things, there…

  • Atomic Show #246 – Carmen Bigles, Coqui Pharmaceuticals Update

    ByRod Adams

    In November 2014, I spoke with Carmen Bigles, the founder of Coqui Pharmaceuticals, a company that is preparing to build a $330 million medical isotope production facility near Gainesville, FL. Since that discussion 11 months ago, Coqui has made steady progress in completing their construction and operating license application to the NRC for a class…

  • The Atomic Show #154 – Atomic Round-up With Five Experts

    ByRod Adams

    Rod Adams got together with Margaret Harding, Dan Yurman, Meredith Angwin, and Charles Barton for a round up of recent atomic industry and technology developments. Topics discussed included new enrichment facilities, enrichment technology, public meetings about new nuclear power plants, and small reactor plant developments. Meredith Angwin is a physical chemist with long experience in…